Reduced MEG3 expression and promoter DNA hypermethylation has been observed in various human tumor types: pituitary adenomas, neuroblastomas, pheochromocytomas, Wilms tumors, and other carcinomas [27]. Here, MEG3 is linked to Nephroblastoma.